Se l'SSN e le sue aziende sanitarie hanno assunto solo recentemente consapevolezza di trovarsi a fronteggiare una 'nuova normalità', e quindi di dover 'cambiare pelle' per fronteggiare le sfide ad essa connesse, per le imprese del Life Science una nuova normalità, forse meglio definibile come...

If the NHS and its healthcare companies have only recently become aware of being faced with a "new normality", and, therefore, of having to "shed their skin" to face the challenges connected to it, a new normality for Life Science companies, perhaps best described as a perfect storm, it has...

The paper deals firstly with the assessment of nonfinancial firm’s risk exposure which has been deeply affected in the last two decades by the trend of market globalization and increased competition. In this new scenario we can note the weakening of the traditional separation between risks...